dactinomycin has been researched along with Hormone-Dependent Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amin, M; Anderson, C; Arnold, RS; Chung, LW; Johnstone, P; Konaka, H; Kubo, H; Logani, S; Marshall, FF; Mousses, S; Nakagawa, M; Petros, JA; Shigemura, K; Sung, SY; Wang, R; Zhau, HE | 1 |
Drago, JR; Gershwin, ME; Goldman, LB | 1 |
Kuramoto, M; Ogawa, M; Yamashita, J | 1 |
3 other study(ies) available for dactinomycin and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
Topics: ADAM Proteins; Adenocarcinoma; Androgens; Antioxidants; Apoptosis; Azoles; Catalase; Cell Hypoxia; Cell Line, Tumor; Cycloheximide; Dactinomycin; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Hydrogen Peroxide; Isoindoles; Male; Membrane Proteins; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Organoselenium Compounds; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species | 2006 |
Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Male; Methotrexate; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Time Factors | 1980 |
Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Topics: Animals; Aromatase Inhibitors; Binding Sites; Cycloheximide; Dactinomycin; Drug Screening Assays, Antitumor; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Pancreatic Neoplasms; Receptors, Estrogen; Tissue Plasminogen Activator; Toremifene; Tumor Cells, Cultured | 1995 |